Gene therapy progress and prospects: nonviral vectors

T Niidome, L Huang - Gene therapy, 2002 - nature.com
The success of gene therapy is largely dependent on the development of the gene delivery
vector. Recently, gene transfection into target cells using naked DNA, which is a simple and …

Magnetic nanoparticles: from fabrication to clinical applications

NTK Thanh - 2012 - books.google.com
Offering the latest information in magnetic nanoparticle (MNP) research, Magnetic
Nanoparticles: From Fabrication to Clinical Applications provides a comprehensive review …

New non-viral method for gene transfer into primary cells

O Gresch, FB Engel, D Nesic, TT Tran, HM England… - Methods, 2004 - Elsevier
The availability of genetically altered cells is an essential prerequisite for many scientific and
therapeutic applications including functional genomics, drug development, and gene …

Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions

NP Gabrielson, DW Pack - Biomacromolecules, 2006 - ACS Publications
We previously reported that gene delivery efficiency of 25-kDa, branched polyethylenimine
(PEI) increased upon acetylation of up to 43% of the primary amines with acetic anhydride …

Hydroxyl stereochemistry and amine number within poly (glycoamidoamine) s affect intracellular DNA delivery

Y Liu, TM Reineke - Journal of the American Chemical Society, 2005 - ACS Publications
Nucleic acid drugs have great potential to treat many devastating aliments, but their
application has been hindered by the lack of efficacious and nontoxic delivery vehicles …

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor

S Hsu, B Yu, X Wang, Y Lu, CR Schmidt, RJ Lee… - … , Biology and Medicine, 2013 - Elsevier
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

H Youn, JK Chung - Expert opinion on biological therapy, 2015 - Taylor & Francis
Introduction: Current gene therapy involves replacement of defective gene by delivery of
healthy genetic material to precede normal function. Virus-mediated gene delivery is the …

Techniques for gene transfer into neurons

P Washbourne, AK McAllister - Current opinion in neurobiology, 2002 - Elsevier
To illuminate the function of the thousands of genes that make up the complexity of the
nervous system, it is critical to be able to introduce and express DNA in neurons. Over the …

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

S de Jong, G Chikh, L Sekirov, S Raney… - Cancer Immunology …, 2007 - Springer
Immunostimulatory oligodeoxynucleotides (ODN) containing cytosine-guanine (CpG) motifs
are powerful stimulators of innate as well as adaptive immune responses, exerting their …

Transposons for gene therapy!

Z Ivics, Z Izsvak - Current gene therapy, 2006 - ingentaconnect.com
Gene therapy is a promising strategy for the treatment of several inherited and acquired
human diseases. Several vector platforms exist for the delivery of therapeutic nucleic acids …